This analysis method for assessing the stage of prostate cancer and this prostate-cancer stage assessment method include a step in which the amount of neuropeptide Y in a sample derived from blood or urine collected from a subject is measured, and this prostate-cancer detection method includes a step in which the amounts of neuropeptide Y and prostate-specific antigen in a sample derived from blood or urine collected from a subject are measured.